Item 5.07 Submission of Matter to a Vote of Security Holders

On June 23, 2022, Fuse Medical, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). The total number of shares of common stock eligible to vote as of the record date, April 25, 2022, was 72,895,795 and, pursuant to the Company's Bylaws, 36,447,898 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of shares of common stock present or represented at the Annual Meeting was 64,158,360, and a quorum therefore existed.



At the Annual Meeting:
1.  Election of Board of Directors. The following persons were elected as

directors of the Company for a one-year term expiring at the 2022 Annual

Meeting of Stockholders with the following vote:




Name                      Votes For  Votes Against Votes Withheld  Broker
                                                                  Non-Votes
Renato V. Bosita, Jr., MD 62,766,475    295,105          0        1,096,780
Mark W. Brooks            62,768,965    292,615          0        1,096,780
Lawrence S. Yellin        62,727,971    333,609          0        1,096,780
Christopher C. Reeg       62,768,975    292,605          0        1,096,780


2.  Ratification of the Selection of Armanino LLP ("Armanino"). The selection of
    Armanino to act as independent registered public accounting firm for the
    Company for the fiscal year ending December 31, 2022 was ratified by a vote
    of (i) 64,140,909 in favor, (ii) 17,381 against, and (iii) 70 abstaining.


                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses